Expression of beta3-adrenoceptor and stimulation of glucose transport by beta3-agonists in brown adipocyte primary culture

J Biochem. 1996 Jan;119(1):120-5. doi: 10.1093/oxfordjournals.jbchem.a021196.

Abstract

Precursor cells of brown adipocytes were isolated from the interscapular brown fat of newborn rats and cultured on collagen-coated dishes. When confluent cells were treated with dexamethasone, mRNAs for muscle/adipocyte type of glucose transporter, hormone-sensitive lipase, and CCAAT/enhancer binding protein alpha were increased remarkably, confirming a predominant effect of dexamethasone on the terminal differentiation of the cultured cells. Effects of dexamethasone on the expression of three subtypes of beta-adrenoceptor were also examined. beta1- and beta2-adrenoceptor mRNAs remained constant regardless of dexamethasone-treatment, while beta3-adrenoceptor mRNA was present only in dexamethasone-treated differentiated cells. To assess the metabolic response mediated by beta3-adrenoceptor, glucose transport into the cells was estimated. Norepinephrine enhanced glucose transport in dexamethasone-treated differentiated cells, but not in undifferentiated cells. beta3-Adrenergic agonists mimicked completely the stimulatory effect of norepinephrine at concentrations lower by two orders of magnitude. These results suggest that the beta3-adrenoceptor is expressed during the course of differentiation in brown adipocytes and plays a significant role in the response of glucose transport to adrenergic stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue, Brown / cytology
  • Adipose Tissue, Brown / drug effects
  • Adipose Tissue, Brown / metabolism*
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Base Sequence
  • Biological Transport / drug effects
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / genetics
  • Deoxyglucose / pharmacokinetics
  • Dexamethasone / pharmacology
  • Dioxoles / pharmacology
  • Enhancer Elements, Genetic
  • Ethanolamines / pharmacology
  • Glucose / metabolism*
  • Glucose Transporter Type 4
  • Isoenzymes
  • Molecular Sequence Data
  • Monosaccharide Transport Proteins / drug effects
  • Monosaccharide Transport Proteins / genetics
  • Muscle Proteins*
  • Norepinephrine / pharmacology
  • Phospholipases A / metabolism
  • RNA, Messenger / analysis
  • Rats
  • Receptors, Adrenergic, beta / biosynthesis*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • DNA-Binding Proteins
  • Dioxoles
  • Ethanolamines
  • Glucose Transporter Type 4
  • Isoenzymes
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • RNA, Messenger
  • Receptors, Adrenergic, beta
  • Slc2a4 protein, rat
  • disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate
  • BRL 37344
  • Dexamethasone
  • Deoxyglucose
  • Phospholipases A
  • Glucose
  • Norepinephrine